CN108465076A - 一种治疗皮炎、湿疹的抑菌乳膏及其制备方法 - Google Patents
一种治疗皮炎、湿疹的抑菌乳膏及其制备方法 Download PDFInfo
- Publication number
- CN108465076A CN108465076A CN201810535883.4A CN201810535883A CN108465076A CN 108465076 A CN108465076 A CN 108465076A CN 201810535883 A CN201810535883 A CN 201810535883A CN 108465076 A CN108465076 A CN 108465076A
- Authority
- CN
- China
- Prior art keywords
- parts
- eczema
- antibacterial
- emulsifiable paste
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 48
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 25
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 54
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 51
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960003260 chlorhexidine Drugs 0.000 claims abstract description 18
- -1 alkyl phenol Chemical compound 0.000 claims abstract description 17
- 229940051841 polyoxyethylene ether Drugs 0.000 claims abstract description 17
- 229920000056 polyoxyethylene ether Polymers 0.000 claims abstract description 17
- 238000011282 treatment Methods 0.000 claims abstract description 17
- 241001645380 Bassia scoparia Species 0.000 claims abstract description 12
- 240000000774 Cunila origanoides Species 0.000 claims abstract description 12
- 235000018274 Cunila origanoides Nutrition 0.000 claims abstract description 12
- 235000014866 Dictamnus albus Nutrition 0.000 claims abstract description 12
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 12
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 12
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 12
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 12
- 240000004980 Rheum officinale Species 0.000 claims abstract description 12
- 241001671204 Stemona Species 0.000 claims abstract description 12
- 239000004359 castor oil Substances 0.000 claims abstract description 12
- 235000019438 castor oil Nutrition 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 12
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims abstract description 6
- 239000002674 ointment Substances 0.000 claims abstract description 5
- 230000035876 healing Effects 0.000 claims abstract description 4
- 231100000331 toxic Toxicity 0.000 claims abstract description 4
- 230000002588 toxic effect Effects 0.000 claims abstract description 4
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 abstract description 9
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010033733 Papule Diseases 0.000 description 3
- 206010037083 Prurigo Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 206010012435 Dermatitis and eczema Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 201000009053 Neurodermatitis Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 241000143060 Americamysis bahia Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000035357 Focal Infection Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046750 Urticaria papular Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 208000008664 papular urticaria Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗皮炎、湿疹的抑菌乳膏及其制备方法,属于治疗皮炎、湿疹等引起瘙痒性皮肤病的药物技术领域;其中各组分的重量份为白藓皮3‑6份、地肤子2‑5份、苦参1‑4份、蛇床子1‑4份、百部1‑4份、大黄2‑5份、薄荷2‑5份、蓖麻油20‑30份、醋酸氯已定1‑4份、烷基酚聚氧乙烯醚1‑3份、丙二醇2‑4份;本产品是基于现代中医与西医对手足藓发病机理的认识及治疗原则,精选中西医药物原料,采用独特配方配制而成,治疗时,涂抹适量本抑菌软膏于患处,一日一次或两次,1‑3个月可基本治愈,治愈后不易复发,无毒副作用。
Description
技术领域
本发明涉及一种乳膏及其制备方法,具体涉及一种治疗皮炎、湿疹的抑菌乳膏及其制备方法,属于治疗皮炎、湿疹等引起瘙痒性皮肤病的药物技术领域。
背景技术
瘙痒是许多皮肤病共有的一种自觉症状,如仅有皮肤瘙痒而无原发性皮肤损害时则称为瘙痒病。本病原因复杂,实验证明,皮肤存在痒感的感受器,并通过神经末梢传向大脑。患部组织胺的释放能促进痒感。抓痒因压痛有止痒作用,但又促进释放更多的组织胺,加重痒感,形成痒—抓的恶性循环,导致更为严重的皮肤损伤和炎症。
皮炎湿疹的发病原因非常复杂,简单的分为内在因素和外在因素,二者之间难分主次,通常是互相联系,协同作用。外因如化学制剂、化妆品、动物毒素、鱼虾、花粉、尘埃、日晒、搔抓等。内因包括遗传因素、精神因素、机体的免疫因素、代谢因素等。心理因素对皮炎湿疹类皮肤病的影响越来越受到重视,皮炎湿疹的发生还可能与饮食、生活规律、环境等有一定关系。
痒疹是急性或慢性炎症性皮肤病的总称,包括一组皮损相似的瘙痒性疾病,好发于四肢伸侧,其主要损害为风团样丘疹、结节和皮疹,奇痒难忍。痒疹有不同的命名,没有一致的分类方法。由于临床表现不同,痒疹可分称为丘疹性荨麻疹、小儿痒疹、寻常性痒疹、结节性痒疹和妊娠痒疹等。本病的原因不明,多数学者认为与超敏反应有关,也可能与神经精神因素、遗传过敏体质有关,其他因素如虫咬、食物或药物过病灶感染、胃肠道功能紊乱、妊娠及内分泌障碍等也常有影响。
中医认为皮肤瘙痒多由湿热蕰于肌肤,或血虚肝旺、生风生燥、肌肤失养或肝胆湿热下注,或感染滴虫毒邪,或病久脾虚、肝肾不足,或冲任不调,兼因湿热内蕰所致。治则以清热祛风止痒或养血祛风活血化瘀。
发明内容
本发明目的是提供一种祛风止痒、化瘀散结、无毒副作用的治疗皮炎、湿疹的抑菌乳膏。为实现上述目的,本发明采用如下技术方案:
一种治疗皮炎、湿疹的抑菌乳膏,其各组分的重量份为:
白藓皮3-6份、地肤子2-5份、苦参1-4份、蛇床子1-4份、百部1-4份、大黄2-5份、薄荷2-5份、蓖麻油20-30份、醋酸氯已定1-4份、烷基酚聚氧乙烯醚1-3份、丙二醇2-4份
白藓皮5-6份、地肤子2-3份、苦参3-4份、蛇床子1-2份、百部3-4份、大黄2-4份、薄荷3-5份、蓖麻油20-30份、醋酸氯已定1-2份、烷基酚聚氧乙烯醚1-2份、丙二醇3-4份
白藓皮3-4份、地肤子4-5份、苦参1-3份、蛇床子3-4份、百部1-3份、大黄4-5份、薄荷2-3份、蓖麻油30-40份、醋酸氯已定3-4份、烷基酚聚氧乙烯醚2-3份、丙二醇2-3份
白藓皮4-6份、地肤子3-5份、苦参2-3份、蛇床子2-3份、百部2-4份、大黄3-4份、薄荷4-5份、蓖麻油25-35份、醋酸氯已定2-4份、烷基酚聚氧乙烯醚1-2份、丙二醇2-3份
一种治疗皮炎、湿疹的抑菌乳膏制备方法,包括以下步骤:
(1)将所述的原料用粉碎机粉碎成细粉,加入药材总重量 10-30倍量的纯化水煎煮 2-3h,过滤,收集滤液;再在药渣中加入药材重量 8-15 倍量的水煎煮 1-2h,过滤,收集滤液,将两次滤液合并,浓缩至半固态的浸膏;
(2)将浸膏冷冻干燥,粉碎过 200 目筛,得到中药药粉;
(3)在乙醇中取醋酸氯已定份与中药药粉混合,在 70 ~ 80℃水浴锅中加热,熔化,加入烷基酚聚氧乙烯醚、丙二醇,待充分乳化后,搅拌并逐步冷却、搅匀,得白色乳膏基质,即制得本产品。
本发明的优点和有益效果是:本抑菌软膏是基于现代中医与西医对手足藓发病机理的认识及治疗原则,精选中西医药物原料,采用独特配方配制而成,治疗时,涂抹适量本抑菌软膏于患处,一日一次或两次,1-3个月可基本治愈,治愈后不易复发,无毒副作用。
具体实施方式
以下结合本发明实施例对本发明产品作进一步描述,实施例的描述仅为便于理解和应用本发明,而非对本发明保护的限制。 除非特别说明,本发明中的%均为质量百分数;除非特别说明,制备过程在常温、常压状态下进行;除非特别说明,本发明中采用的试剂、方法和设备为本技术领域常规试剂、方法和设备;除非特别说明,本发明中采用的试验条件为本技术领域常规试验条件;除非特别说明,本发明中所用试剂均为市购。
实施例1
一种治疗皮炎、湿疹的抑菌乳膏,其各组分的重量份为:
白藓皮6份、地肤子2份、苦参4份、蛇床子1份、百部4份、大黄2份、薄荷5份、蓖麻油20份、醋酸氯已定4份、烷基酚聚氧乙烯醚3份、丙二醇2份。
一种治疗皮炎、湿疹的抑菌乳膏制备方法,包括以下步骤:
(1)将所述的原料用粉碎机粉碎成细粉,加入药材总重量 10-30倍量的纯化水煎煮 2-3h,过滤,收集滤液;再在药渣中加入药材重量 8-15 倍量的水煎煮 1-2h,过滤,收集滤液,将两次滤液合并,浓缩至半固态的浸膏;
(2)将浸膏冷冻干燥,粉碎过 200 目筛,得到中药药粉;
(3)以1:1的比例在乙醇中取醋酸氯已定份与中药药粉混合,在 70 ~ 80℃水浴锅中加热,熔化,加入烷基酚聚氧乙烯醚、丙二醇,待充分乳化后,搅拌并逐步冷却、搅匀,得白色乳膏基质,即制得本产品。
实施例2
一种治疗皮炎、湿疹的抑菌乳膏,其各组分的重量份为:
白藓皮5-6份、地肤子2-3份、苦参3-4份、蛇床子1-2份、百部3-4份、大黄2-4份、薄荷3-5份、蓖麻油20-30份、醋酸氯已定1-2份、烷基酚聚氧乙烯醚1-2份、丙二醇3-4份
一种治疗皮炎、湿疹的抑菌乳膏制备方法,包括以下步骤:
(1)将所述的原料用粉碎机粉碎成细粉,加入药材总重量 10-30倍量的纯化水煎煮 2-3h,过滤,收集滤液;再在药渣中加入药材重量 8-15 倍量的水煎煮 1-2h,过滤,收集滤液,将两次滤液合并,浓缩至半固态的浸膏;
(2)将浸膏冷冻干燥,粉碎过 200 目筛,得到中药药粉;
(3)以1:1的比例在乙醇中取醋酸氯已定份与中药药粉混合,在 70 ~ 80℃水浴锅中加热,熔化,加入烷基酚聚氧乙烯醚、丙二醇,待充分乳化后,搅拌并逐步冷却、搅匀,得白色乳膏基质,即制得本产品。
实施例3
一种治疗皮炎、湿疹的抑菌乳膏,其各组分的重量份为:
白藓皮3-4份、地肤子4-5份、苦参1-3份、蛇床子3-4份、百部1-3份、大黄4-5份、薄荷2-3份、蓖麻油30-40份、醋酸氯已定3-4份、烷基酚聚氧乙烯醚2-3份、丙二醇2-3份
一种治疗皮炎、湿疹的抑菌乳膏制备方法,包括以下步骤:
(1)将所述的原料用粉碎机粉碎成细粉,加入药材总重量 10-30倍量的纯化水煎煮 2-3h,过滤,收集滤液;再在药渣中加入药材重量 8-15 倍量的水煎煮 1-2h,过滤,收集滤液,将两次滤液合并,浓缩至半固态的浸膏;
(2)将浸膏冷冻干燥,粉碎过 200 目筛,得到中药药粉;
(3)以1:1的比例在乙醇中取醋酸氯已定份与中药药粉混合,在 70 ~ 80℃水浴锅中加热,熔化,加入烷基酚聚氧乙烯醚、丙二醇,待充分乳化后,搅拌并逐步冷却、搅匀,得白色乳膏基质,即制得本产品。
临床实验报告:
1. 一般资料
1.1 将患者分成治疗组422例,女性患者235例,男性患者187例,其中 2.5-17岁143例,18-60岁217例,61-85 岁62例,病程最短1天,最长12 年。对照组354例,女性患者218 例,男性患者 136例。
1.2 诊断标准:全部病例均按人民卫生出版社《皮肤性病学》的诊断标准。
1.3 临床表现:
(1)牛皮癣:瘙痒,斑丘疹,鳞屑性红斑,koebner 征粟粒大脓疱以及非对称性外周关节炎。
(2) 神经性皮炎:瘙痒,丘疹,苔藓化,皮肤干燥无渗出,好发于易受摩擦的颈项部,肘关节伸侧,底布等部位。
(3)湿疹:丘疹,丘疱疹,有渗液,结痂,常对称性分布,慢性湿疹有表皮粗糙,苔藓化或有皴裂。
2.治疗方法:
2.1实验组在患处涂抹约15m本抑菌软膏,一日一次或两次,1个月为一个疗程,连续两个疗程。
2.2对照组:按人民卫生出版社《皮肤性病学》常规治疗方法、及标准药物剂量应用。
3. 疗效观察:
3.1 疗效标准:
临床治愈:经治疗后症状全部消失,皮损处完全恢复,皮肤光滑与正常皮肤相同。
有效:症状明显减轻,皮损面积缩小,病情得到控制。
无效:症状无改变。
3.2治疗结果 :
两种治疗结果的比较:
组别 | 例数 | 治疗 | 治愈 | 好转 | 无效 | 对照 | 治愈 | 好转 | 无效 |
牛皮癣 | 232 | 134 | 130 | 3 | 1 | 98 | 48 | 42 | 8 |
神经性皮炎 | 285 | 153 | 151 | 2 | 0 | 132 | 75 | 47 | 10 |
湿疹 | 259 | 135 | 129 | 5 | 1 | 124 | 61 | 52 | 9 |
合计 | 776 | 422 | 410 | 10 | 2 | 354 | 184 | 141 | 27 |
两组治疗后的临床疗效分析,差异性具有显著性意义,表明治疗组的临床疗效优于对照组。
以上所述仅是本发明的应用实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明技术原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (7)
1.一种治疗皮炎、湿疹的抑菌乳膏,其特征在于:其各组分的重量份为:
白藓皮3-6份、地肤子2-5份、苦参1-4份、蛇床子1-4份、百部1-4份、大黄2-5份、薄荷2-5份、蓖麻油20-30份、醋酸氯已定1-4份、烷基酚聚氧乙烯醚1-3份、丙二醇2-4份。
2.一种治疗皮炎、湿疹的抑菌乳膏,其特征在于:其各组分的重量份为:
白藓皮5-6份、地肤子2-3份、苦参3-4份、蛇床子1-2份、百部3-4份、大黄2-4份、薄荷3-5份、蓖麻油20-30份、醋酸氯已定1-2份、烷基酚聚氧乙烯醚1-2份、丙二醇3-4份。
3.一种治疗皮炎、湿疹的抑菌乳膏,其特征在于:其各组分的重量份为:
白藓皮3-4份、地肤子4-5份、苦参1-3份、蛇床子3-4份、百部1-3份、大黄4-5份、薄荷2-3份、蓖麻油30-40份、醋酸氯已定3-4份、烷基酚聚氧乙烯醚2-3份、丙二醇2-3份。
4.一种治疗皮炎、湿疹的抑菌乳膏,其特征在于:其各组分的重量份为:
白藓皮4-6份、地肤子3-5份、苦参2-3份、蛇床子2-3份、百部2-4份、大黄3-4份、薄荷4-5份、蓖麻油25-35份、醋酸氯已定2-4份、烷基酚聚氧乙烯醚1-2份、丙二醇2-3份。
5.一种治疗皮炎、湿疹的抑菌乳膏,其特征在于:所述的抑菌乳膏精选了中西医药物原料,采用独特配方配制而成,治疗时,涂抹适量本抑菌软膏于患处,一日一次或两次,1-3个月基本治愈,治愈后不易复发,无毒副作用。
6.一种治疗皮炎、湿疹的抑菌乳膏制备方法,包括以下步骤:
(1)将所述的原料用粉碎机粉碎成细粉,加入药材总重量 10-30倍量的纯化水煎煮 2-3h,过滤,收集滤液;再在药渣中加入药材重量 8-15 倍量的水煎煮 1-2h,过滤,收集滤液,将两次滤液合并,浓缩至半固态的浸膏;
(2)将浸膏冷冻干燥,粉碎过 200 目筛,得到中药药粉;
(3)在乙醇中取醋酸氯已定份与中药药粉混合,在 70 ~ 80℃水浴锅中加热,熔化,加入烷基酚聚氧乙烯醚、丙二醇,待充分乳化后,搅拌并逐步冷却、搅匀,得白色乳膏基质,即制得本产品。
7.根据权利要求6所述的方法,其特征在于:加入了西药醋酸氯已定和各种中药相结合。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810535883.4A CN108465076A (zh) | 2018-05-30 | 2018-05-30 | 一种治疗皮炎、湿疹的抑菌乳膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810535883.4A CN108465076A (zh) | 2018-05-30 | 2018-05-30 | 一种治疗皮炎、湿疹的抑菌乳膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108465076A true CN108465076A (zh) | 2018-08-31 |
Family
ID=63261737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810535883.4A Withdrawn CN108465076A (zh) | 2018-05-30 | 2018-05-30 | 一种治疗皮炎、湿疹的抑菌乳膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108465076A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111632119A (zh) * | 2020-06-10 | 2020-09-08 | 山东维赫生物科技有限公司 | 一种复方抑菌薄荷乳膏及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679754A (zh) * | 2005-01-20 | 2005-10-12 | 李木林 | 一种治疗多种皮肤病的强效外用制剂 |
CN101518608A (zh) * | 2009-03-30 | 2009-09-02 | 四川农业大学 | 一种抗念珠球菌的乳膏剂及其制备方法 |
CN102204981A (zh) * | 2010-03-29 | 2011-10-05 | 中国人民解放军第二军医大学 | 一种抗皮炎湿疹的中药复方洗剂 |
-
2018
- 2018-05-30 CN CN201810535883.4A patent/CN108465076A/zh not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679754A (zh) * | 2005-01-20 | 2005-10-12 | 李木林 | 一种治疗多种皮肤病的强效外用制剂 |
CN101518608A (zh) * | 2009-03-30 | 2009-09-02 | 四川农业大学 | 一种抗念珠球菌的乳膏剂及其制备方法 |
CN102204981A (zh) * | 2010-03-29 | 2011-10-05 | 中国人民解放军第二军医大学 | 一种抗皮炎湿疹的中药复方洗剂 |
Non-Patent Citations (1)
Title |
---|
冼峰: "中药外洗治疗慢性湿疹治验", 《新中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111632119A (zh) * | 2020-06-10 | 2020-09-08 | 山东维赫生物科技有限公司 | 一种复方抑菌薄荷乳膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108578615A (zh) | 一种治疗瘙痒性皮肤病的抑菌软膏制备方法 | |
CN108514572A (zh) | 一种抗炎和修复皮肤屏障的中药组合物、提取物及制剂 | |
CN111870568B (zh) | 一种抗敏止痒植物组合物及其制备方法与用途 | |
CN102755573A (zh) | 一种治疗灰指甲的外用中药 | |
CN108619435A (zh) | 一种治疗皮炎、湿疹、痒疹的抑菌水剂及其制备方法 | |
CN105769741A (zh) | 一种适用于敏感性肌肤的美白面膜水及其制备方法 | |
CN111184844A (zh) | 草本抑菌乳膏 | |
CN108465076A (zh) | 一种治疗皮炎、湿疹的抑菌乳膏及其制备方法 | |
CN109549958B (zh) | 治疗激素依赖性皮炎的组合物及其制备方法 | |
CN104606601B (zh) | 一种治疗皮肤湿疹的中药制剂及其制备方法 | |
CN105535822A (zh) | 治疗痔疮的中药组合物及其制备方法 | |
CN107260844A (zh) | 一种抑菌喷剂 | |
CN108785429A (zh) | 一种具有舒缓修复功效的外用中药组合物及其制备方法 | |
CN112716857A (zh) | 一种具有祛痘功效的外用药液及其制备方法 | |
CN102145072A (zh) | 一种治疗小儿湿疹及皮炎类皮肤病的中药组合物 | |
CN105833123A (zh) | 治疗脉络疾病的中药组合物及其制备方法 | |
CN111939095A (zh) | 一种皮肤修护液及其制备方法 | |
CN106822300B (zh) | 一种祛痘美颜的中药制剂 | |
CN104971202A (zh) | 治疗疥癣的外用软膏剂及制法 | |
CN110302269A (zh) | 一种温经通络泡脚液 | |
CN103920124A (zh) | 一种杀菌护肤冻疮膏 | |
CN109432211A (zh) | 用于银屑病和湿疹的中药组合物及其外用药物以及二者的制备方法和应用 | |
CN108743899A (zh) | 草本抑菌剂及其制备方法 | |
CN108888660A (zh) | 一种治疗痤疮或酒糟鼻的低刺激性药物及其制备方法 | |
CN108635530B (zh) | 一种治疗银屑病的外用药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180831 |